- CEO
- Aki Hashimoto
- Full Time Employees
- 683
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Meiji Yasuda Seimei Osaka Midosuji Bldg Osaka OSA Japan 541-0044
- IPO Date
- Oct 1, 1999
- Business
- Stella Chemifa Corporation manufactures and sells high-purity chemicals, primarily fluorides, for semiconductors, batteries, optical materials, and other industrial applications; its core products include ultra-high purity hydrofluoric acid and buffered hydrogen fluoride for wet etching and cleaning of silicon wafers, lithium hexafluorophosphate as an electrolyte for lithium-ion secondary batteries, enriched boron for nuclear energy neutron shielding, boron trifluoride gas as a reactive catalyst, fluorides for optical lenses and surface treatments, and GMP-compliant additives for toothpaste. The company operates through segments encompassing high-purity chemicals, transportation and logistics via subsidiary Blue Express Inc., medical research, cosmetics, energy management, and other services such as insurance agency and automobile maintenance. Founded in 1916 and headquartered in Osaka, Japan, Stella Chemifa conducts operations in Japan with factories in Sakai, Izumiotsu, and Kitakyushu, alongside international subsidiaries and affiliates in Singapore, China, and South Korea. Recent developments include the completion of the Next Generation Materials Research Lab in its Sanpo Factory in 2023 to advance new product development; in 2022, Stella Pharma Corporation transitioned from a consolidated subsidiary to an equity-method affiliate following its listing on the Tokyo Stock Exchange Growth Market in 2021; and the company maintains its listing on the Tokyo Stock Exchange Prime Market with ongoing expansions in production capacity exceeding 100,000 tons annually for high-purity chemicals to meet global semiconductor demand.